A
Arianna Carolina Rosa
Researcher at University of Turin
Publications - 44
Citations - 1354
Arianna Carolina Rosa is an academic researcher from University of Turin. The author has contributed to research in topics: Histamine & Receptor. The author has an hindex of 16, co-authored 41 publications receiving 1110 citations. Previous affiliations of Arianna Carolina Rosa include Durham University & University of Florence.
Papers
More filters
Journal ArticleDOI
Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29)
Margherita Gallicchio,Arianna Carolina Rosa,Chiara Dianzani,L Brucato,Elisa Benetti,Massimo Collino,Roberto Fantozzi +6 more
TL;DR: The ability of celecoxib, a selective cyclooxygenase‐2 (COX‐2) inhibitor, to modulate expression of ICAM‐1 and VCAM‐ 1 in the colon cancer cell line HT29 is investigated.
Journal ArticleDOI
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells
Rosalba Minelli,Loredana Serpe,Piergiorgio Pettazzoni,Valerio Giacomo Minero,Giuseppina Barrera,C. L. Gigliotti,Riccardo Mesturini,Arianna Carolina Rosa,Paolo Gasco,Nicoletta Vivenza,Elisabetta Muntoni,Roberto Fantozzi,Umberto Dianzani,G. P. Zara,Chiara Dianzani +14 more
TL;DR: In this paper, the effect of cholbut solid lipid nanoparticles (cholbut SLN) on adhesion and migration of cancer cells was evaluated by a computerized micro-imaging system.
Journal ArticleDOI
Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.
Chiara Dianzani,L Brucato,Margherita Gallicchio,Arianna Carolina Rosa,Massimo Collino,Roberto Fantozzi +5 more
TL;DR: The effects of celecoxib is evaluated on adhesion of HT29 cells to human umbilical vein endothelial cells (HUVEC), mediated by ICAM‐1 and VCAM‐ 1, to assess further the potential protective effects of Celecoxib on cancer development.
Journal ArticleDOI
Angiotensin II induces tumor necrosis factor-α expression and release from cultured human podocytes.
TL;DR: The results show a functional interaction between Ang II and TNF-α and implicate this cytokine as a mediator in Ang II long-term pathoadaptive podocytes changes.
Journal ArticleDOI
Protective effects of peroxisome proliferator-activated receptor agonists on human podocytes: proposed mechanisms of action
Gianluca Miglio,Arianna Carolina Rosa,Lorenza Rattazzi,Cristina Grange,Giovanni Camussi,Roberto Fantozzi +5 more
TL;DR: This work has investigated whether gemfibrozil, GW0742 and pioglitazone protect human podocytes against nutrient deprivation (ND)‐induced cell death and the role of mitochondrial biogenesis as a cytoprotective process.